_id
6919e7b93c536f8df231820a
Ticker
FAB.LSE
Name
Fusion Antibodies PLC
Exchange
LSE
Address
Springbank Industrial Estate, Belfast, United Kingdom, BT17 0QL
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.fusionantibodies.com
Description
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company has a collaboration agreement with the National Cancer Institute for the use of OptiMAL. Fusion Antibodies plc was incorporated in 2000 and is based in Belfast, the United Kingdom.
Last Close
142500
Volume
126181
Current Price
15.02
Change
0
Last Updated
2025-12-30T10:53:37.156Z
Image
https://logo.clearbit.com/www.fusionantibodies.com
Ipo Date
-
Market Cap
16196017
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
838000
Cost Of Revenue
653000
Gross Profit
185000
Operating Expenses
1095000
Operating Income
-910000
Interest Expense
10000
Pretax Income
-548000
Net Income
-512000
Eps
-0.004522562685412924
Dividends Per Share
-
Shares Outstanding
113656253
Income Tax Expense
-36000
EBITDA
-476000
Operating Margin
-108.59188544152745
Total Other Income Expense Net
362000
Cash
252000
Short Term Investments
-
Receivables
868000
Inventories
272000
Total Current Assets
1392000
Property Plant Equipment
420000
Total Assets
1812000
Payables
667000
Short Term Debt
105000
Long Term Debt
-
Total Liabilities
1086000
Equity
726000
Bs_currency_symbol
GBP
Depreciation
62000
Change In Working Capital
-139000
Cash From Operations
-575000
Capital Expenditures
60000
Cash From Investing
-60000
Cash From Financing
528000
Net Change In Cash
-107000
Cf_currency_symbol
-
PE
-
PB
2342.171422865014
ROE
-70.52341597796143
ROA
-28.2560706401766
FCF
-635000
Fcf Percent
-0.7577565632458234
Piotroski FScore
0
Health Score
16
Deep Value Investing Score
2
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2.5
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
838000
Quarters > 0 > income Statement > cost Of Revenue
653000
Quarters > 0 > income Statement > gross Profit
185000
Quarters > 0 > income Statement > operating Expenses
1095000
Quarters > 0 > income Statement > operating Income
-910000
Quarters > 0 > income Statement > interest Expense
10000
Quarters > 0 > income Statement > pretax Income
-548000
Quarters > 0 > income Statement > net Income
-512000
Quarters > 0 > income Statement > eps
-0.004522562685412924
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
113210150
Quarters > 0 > income Statement > income Tax Expense
-36000
Quarters > 0 > income Statement > EBITDA
-476000
Quarters > 0 > income Statement > operating Margin
-108.59188544152745
Quarters > 0 > income Statement > total Other Income Expense Net
362000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
252000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
868000
Quarters > 0 > balance Sheet > inventories
272000
Quarters > 0 > balance Sheet > total Current Assets
1392000
Quarters > 0 > balance Sheet > property Plant Equipment
420000
Quarters > 0 > balance Sheet > total Assets
1812000
Quarters > 0 > balance Sheet > payables
667000
Quarters > 0 > balance Sheet > short Term Debt
105000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1086000
Quarters > 0 > balance Sheet > equity
726000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-512000
Quarters > 0 > cash Flow > depreciation
62000
Quarters > 0 > cash Flow > change In Working Capital
-139000
Quarters > 0 > cash Flow > cash From Operations
-575000
Quarters > 0 > cash Flow > capital Expenditures
60000
Quarters > 0 > cash Flow > cash From Investing
-60000
Quarters > 0 > cash Flow > cash From Financing
528000
Quarters > 0 > cash Flow > net Change In Cash
-107000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.004522562685412924
Quarters > 0 > ratios > PB
2342.171422865014
Quarters > 0 > ratios > ROE
-70.52341597796143
Quarters > 0 > ratios > ROA
-28.2560706401766
Quarters > 0 > ratios > FCF
-635000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.7577565632458234
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
758000
Quarters > 1 > income Statement > cost Of Revenue
653000
Quarters > 1 > income Statement > gross Profit
105000
Quarters > 1 > income Statement > operating Expenses
1090000
Quarters > 1 > income Statement > operating Income
-985000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-985000
Quarters > 1 > income Statement > net Income
-955000
Quarters > 1 > income Statement > eps
-0.009907317717076801
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
96393396
Quarters > 1 > income Statement > income Tax Expense
30000
Quarters > 1 > income Statement > EBITDA
-888000
Quarters > 1 > income Statement > operating Margin
-129.9472295514512
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
359000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
332000
Quarters > 1 > balance Sheet > inventories
269000
Quarters > 1 > balance Sheet > total Current Assets
1260000
Quarters > 1 > balance Sheet > property Plant Equipment
63000
Quarters > 1 > balance Sheet > total Assets
1323000
Quarters > 1 > balance Sheet > payables
372000
Quarters > 1 > balance Sheet > short Term Debt
40000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
654000
Quarters > 1 > balance Sheet > equity
669000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-955000
Quarters > 1 > cash Flow > depreciation
45000
Quarters > 1 > cash Flow > change In Working Capital
-35000
Quarters > 1 > cash Flow > cash From Operations
-612000
Quarters > 1 > cash Flow > capital Expenditures
10000
Quarters > 1 > cash Flow > cash From Investing
-9000
Quarters > 1 > cash Flow > cash From Financing
542000
Quarters > 1 > cash Flow > net Change In Cash
-80000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.009907317717076801
Quarters > 1 > ratios > PB
2164.1686217040356
Quarters > 1 > ratios > ROE
-142.75037369207772
Quarters > 1 > ratios > ROA
-72.18442932728647
Quarters > 1 > ratios > FCF
-622000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.820580474934037
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
1207000
Quarters > 2 > income Statement > cost Of Revenue
882000
Quarters > 2 > income Statement > gross Profit
325000
Quarters > 2 > income Statement > operating Expenses
1119000
Quarters > 2 > income Statement > operating Income
-794000
Quarters > 2 > income Statement > interest Expense
2000
Quarters > 2 > income Statement > pretax Income
-792000
Quarters > 2 > income Statement > net Income
-758000
Quarters > 2 > income Statement > eps
-0.013643885937113565
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
55556020
Quarters > 2 > income Statement > income Tax Expense
-34000
Quarters > 2 > income Statement > EBITDA
-736000
Quarters > 2 > income Statement > operating Margin
-65.78293289146644
Quarters > 2 > income Statement > total Other Income Expense Net
2000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
439000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
762000
Quarters > 2 > balance Sheet > inventories
230000
Quarters > 2 > balance Sheet > total Current Assets
1431000
Quarters > 2 > balance Sheet > property Plant Equipment
97000
Quarters > 2 > balance Sheet > total Assets
1528000
Quarters > 2 > balance Sheet > payables
417000
Quarters > 2 > balance Sheet > short Term Debt
46000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
469000
Quarters > 2 > balance Sheet > equity
1059000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-758000
Quarters > 2 > cash Flow > depreciation
60000
Quarters > 2 > cash Flow > change In Working Capital
151000
Quarters > 2 > cash Flow > cash From Operations
-752000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
4000
Quarters > 2 > cash Flow > cash From Financing
-11000
Quarters > 2 > cash Flow > net Change In Cash
-760000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.013643885937113565
Quarters > 2 > ratios > PB
787.9616812086874
Quarters > 2 > ratios > ROE
-71.57695939565627
Quarters > 2 > ratios > ROA
-49.60732984293193
Quarters > 2 > ratios > FCF
-752000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.6230323115161558
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
595000
Quarters > 3 > income Statement > cost Of Revenue
651000
Quarters > 3 > income Statement > gross Profit
-56000
Quarters > 3 > income Statement > operating Expenses
818000
Quarters > 3 > income Statement > operating Income
-873000
Quarters > 3 > income Statement > interest Expense
2000
Quarters > 3 > income Statement > pretax Income
-869000
Quarters > 3 > income Statement > net Income
-869000
Quarters > 3 > income Statement > eps
-0.017030400617343202
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
51026398
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-773000
Quarters > 3 > income Statement > operating Margin
-146.72268907563023
Quarters > 3 > income Statement > total Other Income Expense Net
4000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1199000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
557000
Quarters > 3 > balance Sheet > inventories
460000
Quarters > 3 > balance Sheet > total Current Assets
2262000
Quarters > 3 > balance Sheet > property Plant Equipment
158000
Quarters > 3 > balance Sheet > total Assets
2420000
Quarters > 3 > balance Sheet > payables
283000
Quarters > 3 > balance Sheet > short Term Debt
40000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
627000
Quarters > 3 > balance Sheet > equity
1793000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-869000
Quarters > 3 > cash Flow > depreciation
94000
Quarters > 3 > cash Flow > change In Working Capital
5000
Quarters > 3 > cash Flow > cash From Operations
-419000
Quarters > 3 > cash Flow > capital Expenditures
2000
Quarters > 3 > cash Flow > cash From Investing
-2000
Quarters > 3 > cash Flow > cash From Financing
1131000
Quarters > 3 > cash Flow > net Change In Cash
712000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.017030400617343202
Quarters > 3 > ratios > PB
427.4492459341885
Quarters > 3 > ratios > ROE
-48.466257668711656
Quarters > 3 > ratios > ROA
-35.90909090909091
Quarters > 3 > ratios > FCF
-421000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.7075630252100841
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
1965000
Annuals > 0 > income Statement > cost Of Revenue
1535000
Annuals > 0 > income Statement > gross Profit
430000
Annuals > 0 > income Statement > operating Expenses
2209000
Annuals > 0 > income Statement > operating Income
-1779000
Annuals > 0 > income Statement > interest Expense
3000
Annuals > 0 > income Statement > pretax Income
-1777000
Annuals > 0 > income Statement > net Income
-1713000
Annuals > 0 > income Statement > eps
-0.017866179499513347
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
95879480
Annuals > 0 > income Statement > income Tax Expense
64000
Annuals > 0 > income Statement > EBITDA
-1624000
Annuals > 0 > income Statement > operating Margin
-90.53435114503817
Annuals > 0 > income Statement > total Other Income Expense Net
2000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
359000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
332000
Annuals > 0 > balance Sheet > inventories
269000
Annuals > 0 > balance Sheet > total Current Assets
1260000
Annuals > 0 > balance Sheet > property Plant Equipment
63000
Annuals > 0 > balance Sheet > total Assets
1323000
Annuals > 0 > balance Sheet > payables
372000
Annuals > 0 > balance Sheet > short Term Debt
40000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
654000
Annuals > 0 > balance Sheet > equity
669000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1713000
Annuals > 0 > cash Flow > depreciation
105000
Annuals > 0 > cash Flow > change In Working Capital
116000
Annuals > 0 > cash Flow > cash From Operations
-1364000
Annuals > 0 > cash Flow > capital Expenditures
10000
Annuals > 0 > cash Flow > cash From Investing
-5000
Annuals > 0 > cash Flow > cash From Financing
529000
Annuals > 0 > cash Flow > net Change In Cash
-840000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.017866179499513347
Annuals > 0 > ratios > PB
2084.9559030553064
Annuals > 0 > ratios > ROE
-256.05381165919283
Annuals > 0 > ratios > ROA
-129.47845804988663
Annuals > 0 > ratios > FCF
-1374000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.6992366412213741
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
1136000
Annuals > 1 > income Statement > cost Of Revenue
1401000
Annuals > 1 > income Statement > gross Profit
-265000
Annuals > 1 > income Statement > operating Expenses
2243000
Annuals > 1 > income Statement > operating Income
-2288000
Annuals > 1 > income Statement > interest Expense
5000
Annuals > 1 > income Statement > pretax Income
-2289000
Annuals > 1 > income Statement > net Income
-2226000
Annuals > 1 > income Statement > eps
-0.04006766503432031
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
55556020
Annuals > 1 > income Statement > income Tax Expense
-63000
Annuals > 1 > income Statement > EBITDA
-2065000
Annuals > 1 > income Statement > operating Margin
-201.40845070422534
Annuals > 1 > income Statement > total Other Income Expense Net
-1000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1199000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
557000
Annuals > 1 > balance Sheet > inventories
460000
Annuals > 1 > balance Sheet > total Current Assets
2262000
Annuals > 1 > balance Sheet > property Plant Equipment
158000
Annuals > 1 > balance Sheet > total Assets
2420000
Annuals > 1 > balance Sheet > payables
283000
Annuals > 1 > balance Sheet > short Term Debt
40000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
627000
Annuals > 1 > balance Sheet > equity
1793000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-2226000
Annuals > 1 > cash Flow > depreciation
220000
Annuals > 1 > cash Flow > change In Working Capital
-68000
Annuals > 1 > cash Flow > cash From Operations
-1769000
Annuals > 1 > cash Flow > capital Expenditures
2000
Annuals > 1 > cash Flow > cash From Investing
1000
Annuals > 1 > cash Flow > cash From Financing
2770000
Annuals > 1 > cash Flow > net Change In Cash
1004000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.04006766503432031
Annuals > 1 > ratios > PB
450.7628933385388
Annuals > 1 > ratios > ROE
-124.1494701617401
Annuals > 1 > ratios > ROA
-91.98347107438016
Annuals > 1 > ratios > FCF
-1771000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.5589788732394365
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
2901000
Annuals > 2 > income Statement > cost Of Revenue
2699000
Annuals > 2 > income Statement > gross Profit
202000
Annuals > 2 > income Statement > operating Expenses
3035000
Annuals > 2 > income Statement > operating Income
-2833000
Annuals > 2 > income Statement > interest Expense
4000
Annuals > 2 > income Statement > pretax Income
-2859000
Annuals > 2 > income Statement > net Income
-2596000
Annuals > 2 > income Statement > eps
-0.09978879064365538
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
26014946
Annuals > 2 > income Statement > income Tax Expense
-263000
Annuals > 2 > income Statement > EBITDA
-2483000
Annuals > 2 > income Statement > operating Margin
-97.65598069631162
Annuals > 2 > income Statement > total Other Income Expense Net
-1000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
195000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
953000
Annuals > 2 > balance Sheet > inventories
539000
Annuals > 2 > balance Sheet > total Current Assets
1687000
Annuals > 2 > balance Sheet > property Plant Equipment
375000
Annuals > 2 > balance Sheet > total Assets
2062000
Annuals > 2 > balance Sheet > payables
480000
Annuals > 2 > balance Sheet > short Term Debt
70000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
939000
Annuals > 2 > balance Sheet > equity
1123000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-2596000
Annuals > 2 > cash Flow > depreciation
372000
Annuals > 2 > cash Flow > change In Working Capital
566000
Annuals > 2 > cash Flow > cash From Operations
-1755000
Annuals > 2 > cash Flow > capital Expenditures
114000
Annuals > 2 > cash Flow > cash From Investing
-114000
Annuals > 2 > cash Flow > cash From Financing
7000
Annuals > 2 > cash Flow > net Change In Cash
-1854000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.09978879064365538
Annuals > 2 > ratios > PB
337.00822031950133
Annuals > 2 > ratios > ROE
-231.16651825467497
Annuals > 2 > ratios > ROA
-125.89718719689623
Annuals > 2 > ratios > FCF
-1869000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.6442605997931747
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
4799000
Annuals > 3 > income Statement > cost Of Revenue
3082000
Annuals > 3 > income Statement > gross Profit
1717000
Annuals > 3 > income Statement > operating Expenses
3049000
Annuals > 3 > income Statement > operating Income
-1332000
Annuals > 3 > income Statement > interest Expense
9000
Annuals > 3 > income Statement > pretax Income
-1333000
Annuals > 3 > income Statement > net Income
-1200000
Annuals > 3 > income Statement > eps
-0.04625029580918361
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25945780
Annuals > 3 > income Statement > income Tax Expense
-133000
Annuals > 3 > income Statement > EBITDA
-573000
Annuals > 3 > income Statement > operating Margin
-27.75578245467806
Annuals > 3 > income Statement > total Other Income Expense Net
-8000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
2049000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1648000
Annuals > 3 > balance Sheet > inventories
585000
Annuals > 3 > balance Sheet > total Current Assets
4282000
Annuals > 3 > balance Sheet > property Plant Equipment
633000
Annuals > 3 > balance Sheet > total Assets
4915000
Annuals > 3 > balance Sheet > payables
466000
Annuals > 3 > balance Sheet > short Term Debt
132000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1231000
Annuals > 3 > balance Sheet > equity
3684000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-1200000
Annuals > 3 > cash Flow > depreciation
751000
Annuals > 3 > cash Flow > change In Working Capital
127000
Annuals > 3 > cash Flow > cash From Operations
-330000
Annuals > 3 > cash Flow > capital Expenditures
258000
Annuals > 3 > cash Flow > cash From Investing
-258000
Annuals > 3 > cash Flow > cash From Financing
-46000
Annuals > 3 > cash Flow > net Change In Cash
-637000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.04625029580918361
Annuals > 3 > ratios > PB
102.45765968621065
Annuals > 3 > ratios > ROE
-32.57328990228013
Annuals > 3 > ratios > ROA
-24.41505595116989
Annuals > 3 > ratios > FCF
-588000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.12252552615128151
Annuals > 3 > health Score
27
Valuation > metrics > PE
-0.004522562685412924
Valuation > metrics > PB
2342.171422865014
Valuation > final Score
20
Valuation > verdict
77972.4% Overvalued
Profitability > metrics > ROE
-70.52341597796143
Profitability > metrics > ROA
-36.7816091954023
Profitability > metrics > Net Margin
-0.6109785202863962
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.4958677685950412
Risk > metrics > Interest Coverage
-91
Risk > final Score
-334
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.8031088082901554
Liquidity > metrics > Quick Ratio
1.450777202072539
Liquidity > final Score
95
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
7
Prev Risks > 1
-1528
Prev Risks > 2
-1686
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:17.020Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-18
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-04
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.01
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-28
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-19
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.01
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-06-30
Earnings History > 4 > report Date
2023-09-29
Earnings History > 4 > date
2023-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-4.3
Earnings History > 4 > eps Difference
4.3
Earnings History > 4 > surprise Percent
100
Earnings History > 5 > period
2022-09-30
Earnings History > 5 > report Date
2022-12-05
Earnings History > 5 > date
2022-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.04
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-06-30
Earnings History > 6 > report Date
2022-09-01
Earnings History > 6 > date
2022-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.02
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-09-30
Earnings History > 7 > report Date
2021-12-06
Earnings History > 7 > date
2021-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.02
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-06-30
Earnings History > 8 > report Date
2021-08-16
Earnings History > 8 > date
2021-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.09
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-09-30
Earnings History > 9 > report Date
2020-11-20
Earnings History > 9 > date
2020-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.02
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-06-30
Earnings History > 10 > report Date
2020-08-19
Earnings History > 10 > date
2020-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-09-30
Earnings History > 11 > report Date
2019-12-02
Earnings History > 11 > date
2019-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.02
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-06-30
Earnings History > 12 > report Date
2019-08-14
Earnings History > 12 > date
2019-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.06
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.06
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-09-30
Earnings History > 13 > report Date
2018-11-26
Earnings History > 13 > date
2018-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.03
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-06-30
Earnings History > 14 > report Date
2018-08-16
Earnings History > 14 > date
2018-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.05
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.05
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-18
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-03-31
Earnings History > 16 > report Date
2017-05-04
Earnings History > 16 > date
2017-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-09-30
Earnings History > 17 > report Date
2016-11-04
Earnings History > 17 > date
2016-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company has a collaboration agreement with the National Cancer Institute for the use of OptiMAL. Fusion Antibodies plc was incorporated in 2000 and is based in Belfast, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAcquisition of ECI and Capital Raise - 07:00:01 05 Jun 2025 - ROSE News article London Stock Exchange
Read more →Showing 2 of 4
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Fusion Antibodies PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-09-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.